相关实验视频

Updated: Sep 14, 2025

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections

Published on: October 31, 2017

工程值,精子结合性拉米宁-IgG混合抗体,用于强大的非激素避孕药

Alison Schaefer¹, Keiichiro Kushiro², Bhawana Shrestha³

¹Department of Biomedical Engineering, University of North Carolina - Chapel Hill, Morrisville, NC, USA.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

|July 23, 2025

概括

一个新的抗体平台创造了强大的非荷尔蒙避孕药. 一种新的抗体LamH10,有效地凝结精子,为未满足的避孕需求提供了一个有希望的解决方案.

科学领域:

生殖生物学生殖生物学
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

意外怀孕的高率凸显了对有效的非荷尔蒙避孕药的需求.
目前基于抗体的方法 (IgM,IgG) 在稳定性,效力和可制造性方面面临限制.

研究的目的:

开发一种新的,稳定的和强大的多价值抗体平台,用于非荷尔蒙避孕.
为了描述一个主要候选抗体的疗效和稳定性,LamH10.

主要方法:

通过将Laminin 511域与抗体碎片 (Fabs) 和IgG1-Fc.c.融合,设计了一个多价抗体 (mAb) 平台.
开发出针对人类精子的CD52g的多价抗体,LamH10每分子具有10个Fabs.
在羊模型中评估了LamH10的功效,宫性阴道粘液中的稳定性,以及体内疗效.

主要成果:

LamH10在生理温度下表现出纳米分子效能,在酸性条件下表现出稳定性.
在绵羊中,LamH10在低剂量下在2分钟内实现了99%以上的运动精子减少.
拉姆H10在阴道注射几分钟内促进了100%的精子凝结,并且与传统的生物处理相兼容.

结论:

拉米尼-IgG混合mAb平台产生了迄今为止最强大的非激素避孕生物.
LamH10代表了一个稳定的,有效的,可制造的选择,用于按需的避孕.
这种平台技术显示出在多价值抗体开发中更广泛应用的潜力.

关键词:

抗体是对抗体的重要组成部分.宫性阴道抗体的输送非荷尔蒙的避孕措施.

更多相关视频

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians

Published on: May 12, 2019

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

相关概念视频

Birth Control Methods

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...